Showing results (241-250 of 540) with videos related to
Sort By:
Pageof 54
Journal of the American Society of Nephrology : JASN|October 10, 2015
T Cell CX3CR1 Mediates Excess Atherosclerotic Inflammation in Renal ImpairmentLei Dong, Johannes Nordlohne, Shuwang Ge, et al.Stem Cells and Development|November 7, 2013
Urokinase receptor mediates osteogenic differentiation of mesenchymal stem cells and vascular calcification via the complement C5a receptorParnian Kalbasi Anaraki, Margret Patecki, Jan Larmann, et al.Journal of Hypertension|June 7, 2014
Effects on office and home blood pressure of the lercanidipine-enalapril combination in patients with Stage 2 hypertension: a European randomized, controlled clinical trialGiuseppe Mancia, Antonio Coca, Irina Chazova, et al.Transplant International : Official Journal of the European Society for Organ Transplantation|June 29, 2004
Prognostic value of cytotoxic T-lymphocytes and CD40 in biopsies with early renal allograft rejectionMichael Mengel, Imke Mueller, Matthias Behrend, et al.Journal of the American Society of Nephrology : JASN|June 3, 2005
Asymmetric dimethylarginine and progression of chronic kidney disease: the mild to moderate kidney disease studyDanilo Fliser, Florian Kronenberg, Jan T Kielstein, et al.JACC. Basic to Translational Science|August 1, 2018
Aggravated Atherosclerosis and Vascular Inflammation With Reduced Kidney Function Depend on Interleukin-17 Receptor A and Are Normalized by Inhibition of Interleukin-17AJohannes Nordlohne, Alexandra Helmke, Shuwang Ge, et al.Transplantation|July 28, 2012
Factors influencing viral clearing and renal function during polyomavirus BK-associated nephropathy after renal transplantationAnke Schwarz, Silvia Linnenweber-Held, Albert Heim, et al.Blood Pressure|February 21, 2023
RAS-challenge as a first-look test for detection of primary aldosteronism in patients with treatment-resistant hypertensionChristian Beger, Theresa Karg, Jan B Hinrichs, et al.Journal of the American Society of Hypertension : JASH|February 21, 2012
Baroreflex activation therapy provides durable benefit in patients with resistant hypertension: results of long-term follow-up in the Rheos Pivotal TrialGeorge L Bakris, Mitra K Nadim, Hermann Haller, et al.International Journal of Oncology|March 15, 2002
Lack of protein kinase C (PKC)-beta and low PKC-alpha, -delta, -epsilon, and -zeta isozyme levels in proliferating human melanoma cellsKonstantin Krasagakis, Sabine Fimmel, Daniela Genten, et al.Pageof 54